BMJ Open Respiratory Research (Jan 2021)

Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study

  • Jiro Terada,
  • Yuichiro Takeshita,
  • Retsu Fujita,
  • Yasutaka Hirasawa,
  • Taku Kinoshita,
  • Yuri Isaka,
  • Toru Kinouchi,
  • Hiroshi Tajima,
  • Yuji Tada,
  • Shigeru Kiryu,
  • Kenji Tsushima

DOI
https://doi.org/10.1136/bmjresp-2021-000923
Journal volume & issue
Vol. 8, no. 1

Abstract

Read online

Background Although several studies have reported an association between atherosclerosis-related diseases and COVID-19, the relationship between COVID-19 severity and atherosclerosis progression remains unclear. The aim of this study is to determine the coronary artery calcium score (CACS) prognostic value in patients with COVID-19 using indices such as deterioration in oxygenation and CT images of the chest.Methods This was a single-centre retrospective study of 53 consecutive patients with COVID-19 in Narita who were admitted to our hospital between March 2020 and August 2020. CACS was calculated based on non-gated CT scans of the chest performed on admission day. The patients were divided into the following two groups based on CACS: group 1 (CACS ≥180, n=11) and group 2 (CACS <180, n=42). Following univariate analysis of the main variables, multivariate analysis of variables that may be associated with COVID-19 progression was performed.Results Multivariable logistic regression analysis of age, sex, smoking history, diabetes, hypertension, dyslipidaemia, number of days from symptom onset to hospitalisation and CACS of ≥180 was performed. It revealed that unlike CACS of <180, CACS of ≥180 is associated with exacerbation of oxygenation or CT images of the chest during hospitalisation (OR: 12.879, 95% CI: 1.399 to 380.401). Furthermore, this model of eight variables showed good calibration (Hosmer-Lemeshow p=0.119).Conclusion CACS may be a prognosis marker of COVID-19 severity. Although coronary artery calcification is not typically assessed in pneumonia cases, it may provide a valuable clinical indicator for predicting severe COVID-19 outcomes.